CATALOGO DEI PRODOTTI DELLA RICERCA

PIGHI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.531
EU - Europa 2.251
AS - Asia 1.906
SA - Sud America 274
AF - Africa 124
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.469
RU - Federazione Russa 1.163
SG - Singapore 911
IT - Italia 334
CN - Cina 314
BR - Brasile 224
HK - Hong Kong 212
VN - Vietnam 207
DE - Germania 122
FR - Francia 122
GB - Regno Unito 110
IE - Irlanda 96
KR - Corea 73
SE - Svezia 69
FI - Finlandia 54
ES - Italia 40
CA - Canada 36
IN - India 33
PL - Polonia 32
TG - Togo 31
BJ - Benin 29
NL - Olanda 29
NG - Nigeria 22
AT - Austria 21
JP - Giappone 20
BD - Bangladesh 17
ID - Indonesia 17
MX - Messico 17
TN - Tunisia 17
AR - Argentina 16
PH - Filippine 13
IQ - Iraq 11
TR - Turchia 11
LT - Lituania 9
PT - Portogallo 9
UA - Ucraina 9
VE - Venezuela 9
BE - Belgio 8
EC - Ecuador 8
TW - Taiwan 8
ZA - Sudafrica 8
PK - Pakistan 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BH - Bahrain 5
CO - Colombia 5
IR - Iran 5
PE - Perù 5
DK - Danimarca 4
DZ - Algeria 4
MA - Marocco 4
TH - Thailandia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
CL - Cile 3
NP - Nepal 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
Totale 7.092
Salva come PNG Salva come JPEG
Città #
Singapore 522
Dallas 464
San Jose 420
Ashburn 392
Moscow 376
Chandler 244
Hong Kong 205
Verona 119
The Dalles 97
Dublin 91
Ho Chi Minh City 77
Beijing 61
Milan 54
Munich 53
Los Angeles 51
Hanoi 49
London 39
Buffalo 33
Columbus 33
Lomé 31
New York 31
Cotonou 29
Madrid 27
Seattle 27
Redondo Beach 26
Helsinki 25
Warsaw 23
Lawrence 22
Princeton 22
São Paulo 22
Abuja 20
Amsterdam 20
Redmond 20
Santa Clara 19
Boston 18
Seoul 18
Sindelfingen 18
Turku 18
Tokyo 17
Frankfurt am Main 16
Orem 16
Wilmington 16
Montreal 15
Rome 14
Vienna 14
Jakarta 13
Council Bluffs 12
Poplar 12
Brooklyn 11
Denver 11
Haiphong 11
Paris 11
Lappeenranta 10
Tianjin 10
Toronto 10
Chennai 9
Guangzhou 9
Houston 9
Nuremberg 9
Philadelphia 9
Atlanta 8
Brussels 8
Da Nang 8
Hải Dương 8
Lisbon 8
Tunis 8
Ancona 7
Ann Arbor 7
Biên Hòa 7
Chicago 7
Shenzhen 7
Stockholm 7
Taipei 7
Brasília 6
Pescantina 6
Bonndorf 5
Curitiba 5
Des Moines 5
Hyderabad 5
Johannesburg 5
Mexico City 5
Phoenix 5
Rio de Janeiro 5
San Francisco 5
Southend 5
Wroclaw 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Bentivoglio 4
Bexley 4
Can Tho 4
Caracas 4
Caxias do Sul 4
Charlotte 4
Dhaka 4
Istanbul 4
Kyiv 4
Lima 4
Ottawa 4
Totale 4.301
Salva come PNG Salva come JPEG
Nome #
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 245
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 184
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 176
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 163
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 162
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 154
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 153
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 152
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 147
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 145
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 143
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 140
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 138
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 135
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 133
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 131
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 126
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 122
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 122
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 121
Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer 119
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 114
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 112
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 112
Effect of syringe underfilling on the quality of venous blood gas analysis 111
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 110
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 108
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 108
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 107
Monoclonal gammopathy in SARS-CoV-2 infection 106
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 106
Cellular immunity against SARS-CoV-2 depends on the serological status 106
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 105
Impact of the COVID-19 pandemic on the volume of laboratory testing 103
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 101
Limitations of hemolysis-based correction for potassium measurement in hemolyzed whole blood samples 101
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 101
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 98
Methadone metabolite (EDDP) crystals in urine: a case report 96
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 96
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 95
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 95
Evaluating the accuracy of ChatGPT in classifying normal and abnormal blood cell morphology 94
Analytical validation of hemolysis detection on GEM Premier 7000 94
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 90
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 89
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 85
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 84
Correlation between basal humoral immunogenicity and side effects after receiving the bivalent formulation of a mRNA-based vaccine 83
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 79
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 77
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 74
Performance assessment of ChatGPT in classification of urine particles 70
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 68
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 68
Effect of exogenous lipids contamination on blood gas analysis 67
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 66
Evaluation of freely available artificial intelligence (AI) tools for diagnostic support in a complex clinical and laboratory presentations: a pilot study 66
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 66
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 65
Evaluation of the acceptability of proposed hemolysis limits for Werfen ACL-TOP 750 CTS 65
Is mixing of blood gas syringes after collection really necessary? 65
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 62
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 59
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 57
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 57
Evaluation of circadian rhythm of SARS-CoV-2 interferon-gamma release assay (IGRA) in healthy vaccinated individuals: a case-series 49
Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto 45
Assessing Intra- and Inter-Analyzer Imprecision in Automated Hematological Laboratories 33
Analytical performance of the Roche Elecsys TnT hs Gen 6 immunoassay 32
Intra-and inter-analyzer imprecision of cell population data on Sysmex XN-10 18
Decreased Plasma Concentration of Hydrogen Sulfide in Hospitalized COVID-19 Patients: A Novel Determinant of Mortality? 6
Totale 7.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.371
article - articoli 24.887
book - libri 0
conference - conferenze 148
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 336
Totale 50.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 3 2 17
2021/2022205 29 37 7 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/20251.527 65 84 90 185 61 62 64 87 181 139 225 284
2025/20264.425 333 281 405 672 1.139 285 455 285 359 211 0 0
Totale 7.235